Hyderabad Telangana, India

Somashekhar Battini

USPTO Granted Patents = 6 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Somashekhar Battini: Innovator in Pharmaceutical Compositions

Introduction

Somashekhar Battini is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable injectable compositions. With a total of six patents to his name, Battini's work focuses on enhancing the efficacy and safety of pharmaceutical formulations.

Latest Patents

Among his latest patents, Battini has developed stable pharmaceutical compositions of bendamustine. These compositions are designed as ready-to-dilute (RTD) or ready-to-use (RTU) liquid injectable formulations suitable for intravenous administration. The formulations typically include bendamustine or its pharmaceutically acceptable salts, along with at least one non-aqueous solvent. Additionally, they may contain optional excipients and pH adjusters, ensuring that the compositions are antioxidant-free and suitable for parenteral administration. His inventions also encompass methods for manufacturing these stable, antioxidant-free injectable solutions.

Career Highlights

Somashekhar Battini has worked with reputable companies in the pharmaceutical industry, including Slayback Pharma LLC and Azurity Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Battini has collaborated with several professionals in his field, including Harish Govindaraja Setty Chinnari and Sumitra Ashokkumar Pillai. These collaborations have likely enriched his research and development efforts.

Conclusion

Somashekhar Battini is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact patient care. His innovative approaches to injectable formulations demonstrate his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…